All data are based on the daily closing price as of May 12, 2026
s
ScinoPharm Taiwan
1789.TW
0.60 USD
-0.01
-1.64%
Overview
Last close
0.60 usd
Market cap
476.45M usd
52 week high
0.89 usd
52 week low
0.51 usd
Target price
0.57 usd
Valuation
P/E
113.5294
Forward P/E
40.3226
Price/Sales
4.8243
Price/Book Value
1.4876
Enterprise Value
422.11M usd
EV/Revenue
4.2072
EV/EBITDA
19.7474
Key financials
Revenue TTM
100.33M usd
Gross Profit TTM
34.77M usd
EBITDA TTM
19.19M usd
Earnings per Share
0.01 usd
Dividend
N/A usd
Total assets
N/A usd
Net debt
N/A usd
About
ScinoPharm Taiwan, Ltd., a pharmaceutical company, provides active pharmaceutical ingredient (API) development and manufacturing and injectable solutions in Taiwan, rest of Asia, Europe, and the Americas. It offers small molecules, peptide drugs, and steroids; drug products for anticancer, thromboembolic disorders, and osteoporosis; and contract analytical testing, sterile injectables contract manufacturing, and small molecules and peptide contract development and manufacturing organization services. The company was incorporated in 1997 and is headquartered in Tainan City, Taiwan.